Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Options Medical Weight Loss vs Queen RX

Options Medical Weight Loss
Graded #218

Lower grade

vs+0.7999999999999972
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 65.5/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Options Medical Weight Loss is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +23
54
77
Dose & formulationOptions Medical Weight Loss +20
77
57
Clinical oversightOptions Medical Weight Loss +12
81
69
Labs & monitoringEven
53
53
FulfillmentQueen RX +8
67
75
Contract termsQueen RX +6
55
61
Options Medical Weight Loss · left barQueen RX · right bar

The numbers

MetricOptions Medical Weight LossQueen RX
WeighScore65.5/10066.3/100
GradeCC
Scorecard rank#218#192
Semaglutide$199/mo (compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$399/mo (compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard